Serial seizures occur commonly in inpatient epileptic children. This type of seizure due to its characteristics has a significant impact on the patient's health. Untreated serial seizures lead to status epilepticus; therefore, finding a more effective treatment for such patients is essential. This study was performed to compare the outcome of intermittent intravenous diazepam in the pediatric neurology clinic and intravenous midazolam in the pediatric intensive care unit (PICU), in order to introduce an alternative treatment for serial seizures.
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Introduction
Serial seizures, also known as repetitive or cluster seizures, occur commonly in children with epilepsy (1) . At the simplest level, serial seizures have been defined as the number of seizures per unit time with an increased frequency over the patient's typical seizure (1) . There have been several definitions for serial seizures clinically and statistically according to different studies. In studies with a clinical definition for serial seizures, cluster patterns have been defined differently; including two to four seizures in a short period of ≤48 hours (2) ; three or more seizures within 24 hours (3, 4) In most hospitals, the first approach as the routine approach for refractory serial seizure is admission of the patient in the Pediatric Intensive Care Unit (PICU) and starting intravenous midazolam infusion. Limited PICU services in some remote hospitals were the main drawback of this approach. In addition, infusion of midazolam drip cannot be administered in the pediatric neurology ward. Therefore, treatment of refractory serial seizures sometimes becomes a challenging problem. The aim of this study was achievement of a new method for treatment of patients with serial seizures when transfer to the PICU is not possible.
Materials & Methods
This study included all admitted children with refractory serial seizures in Mofid hospital, which is a referral center for pediatric neurological diseases, aged from 6 months to 15 
Results
Overall, 44 children were eligible for our study. We excluded six children owing to early death before treatment (one patient), transport to other hospitals (one patient) and critical situation other than seizure (four patients). Finally, 38 patients, 18 boys and 20 girls (range, 6 months to 15 years) were recruited as refractory serial seizures (RSS) in this study, 18 patients in the midazolam and 20
The safety and efficacy of midazolam has been shown by several clinical studies in the treatment of acute seizures and status epilepticus in adult and children (15) (16) (17) (18) . Midazolam has also successfully controlled serial seizures in children (19) . The current study showed that not only the adverse effects of diazepam were not more than midazolam, but also the duration of admission in PICU in the midazolam group were longer than the diazepam group. Hayashi et al (18) detected that 20% of the patients with status epilepticus treated with midazolam drip had respiratory suppuration and needed mechanical ventilation. This rate in our study was 22.2%, but our patients were clinically different. In that study, 64.5% of the status epilepticus patients had good responses to midazolam drip compared to the 66.6% rate in our study. Early termination of serial seizures is important to prevent adverse consequences and to reduce the risk of development of status epilepticus.
In conclusion, our study showed that intermittent intravenous diazepam may be considered as an effective alternative therapy for midazolam in the treatment of serial seizures, because of similar therapeutic effects and less side effects.
in the diazepam group. Variables such as sex, age, seizure onset age, neurodevelopmental disability and seizure type were not significantly different between the two groups (Table 1) . Before admission, six children were treated with one, 19 with two and others with three antiepileptic drugs. Fourteen children (36.8%) had a definite etiology for seizure.
In the midazolam group, 13 children (72.2 %) had response (12 complete and one partial) to treatment. In the diazepam group 14 (70.0 %) children had response (10 complete and four partial) to treatment (P = 0.373).
In patients with good response, the duration of seizure control was 17.21 ±22.506 hours in the midazolam group and 11.60 ±15.579 hours in the diazepam group. During hospital admission, four of the midazolam group patients and two of the diazepam group patients were intubated and needed mechanical ventilation, which showed no significant difference between the two groups (P= 0.302). Respiratory suppression was related to these drugs in four of the midazolam group and two of the diazepam group patients, after ruling out other conditions such as respiratory infection by a normal chest X-ray and a normal laboratory exam. Bradycardia was seen in one child under treatment with midazolam, but not in the diazepam group. Duration of stay in PICU and mechanical ventilation in the group treated with midazolam was longer than the group treated with diazepam, with no significant difference between the two groups ( Table 2) . In both groups, all patients were discharged and no mortality occurred during treatment.
Discussion
To the best of our knowledge, no controlled studies have compared the efficacy of intermittent intravenous diazepam with intravenous midazolam drip for the management of serial seizures. We found that intermittent diazepam given intravenously is as safe and effective as midazolam drip given intravenously in the management of refractory serial seizures in children. Some investigators have reported the efficacy of rectal diazepam in serial seizures (13, 14) . Dreifuss et al (13) reported an efficacy of rectal diazepam comparable to that obtained with placebo in serial seizures (P< 0.001). 
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